# T. Rowe Price Health Sciences Portfolio

T. Rowe Price Health Sciences Portfolio is a registered fund series of T. ROWE PRICE EQUITY SERIES, INC. (series S000002083). Net assets $662.6M as of 2026-03-31.

## Profile

- Series ID: S000002083
- Registrant: T. ROWE PRICE EQUITY SERIES, INC.
- LEI: 23LI9YJ7764IBT5W0K91
- Net assets: $662.6M
- Total assets: $663.5M
- As of: 2026-03-31

## Advisers

- [T. Rowe Price Associates, Inc. (Advisor)](https://search.stillhousedata.com/firm/105496)

## Top holdings (200 reported)

_Showing 15 of 200 holdings by value._

| Holding | Ticker | Value | % of fund |
| --- | --- | --- | --- |
| [ELI LILLY & CO](https://search.stillhousedata.com/security/532457108) | — | $67.7M | 1021.50% |
| [THERMO FISHER SCIENTIFIC INC](https://search.stillhousedata.com/security/883556102) | — | $27.0M | 407.55% |
| [INTUITIVE SURGICAL INC](https://search.stillhousedata.com/security/46120E602) | — | $24.4M | 368.28% |
| [STRYKER CORP](https://search.stillhousedata.com/security/863667101) | — | $23.1M | 348.87% |
| [MERCK & CO. INC.](https://search.stillhousedata.com/security/58933Y105) | — | $22.9M | 345.73% |
| ASTRAZENECA PLC | — | $21.0M | 317.61% |
| [UNITEDHEALTH GROUP INC](https://search.stillhousedata.com/security/91324P102) | — | $20.5M | 310.05% |
| [ARGENX SE - ADR](https://search.stillhousedata.com/security/04016X101) | — | $19.4M | 292.65% |
| [ABBVIE INC](https://search.stillhousedata.com/security/00287Y109) | — | $19.1M | 288.01% |
| [REGENERON PHARMACEUTICALS](https://search.stillhousedata.com/security/75886F107) | — | $17.8M | 268.20% |
| [GILEAD SCIENCES INC](https://search.stillhousedata.com/security/375558103) | — | $17.3M | 260.99% |
| [JOHNSON & JOHNSON](https://search.stillhousedata.com/security/478160104) | — | $16.3M | 245.69% |
| [VERTEX PHARMACEUTICALS INC](https://search.stillhousedata.com/security/92532F100) | — | $16.1M | 242.91% |
| [DANAHER CORP](https://search.stillhousedata.com/security/235851102) | — | $13.6M | 205.08% |
| [ALNYLAM PHARMACEUTICALS INC](https://search.stillhousedata.com/security/02043Q107) | — | $10.8M | 162.93% |

## Net asset history

| Report date | Net assets |
| --- | --- |
| 2026-03-31 | $662.6M |
| 2025-12-31 | $729.8M |
| 2025-09-30 | $644.4M |
| 2025-06-30 | $631.0M |
| 2025-03-31 | $660.1M |
| 2024-12-31 | $665.6M |
| 2024-09-30 | $755.6M |
| 2024-06-30 | $719.0M |

## More

- [Registrant: T. ROWE PRICE EQUITY SERIES, INC.](https://search.stillhousedata.com/registrant/918294)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/fund/S000002083.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.